A detailed history of Sabal Trust CO transactions in Dyadic International Inc stock. As of the latest transaction made, Sabal Trust CO holds 11,111 shares of DYAI stock, worth $20,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,111
Previous 11,111 -0.0%
Holding current value
$20,222
Previous $16,000 31.25%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$1.52 - $2.04 $16,888 - $22,666
11,111 New
11,111 $17,000
Q3 2019

Oct 15, 2019

BUY
$4.98 - $6.7 $55,332 - $74,443
11,111 New
11,111 $68,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Sabal Trust CO Portfolio

Follow Sabal Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.